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PURPOSE. Retinoic acid (RA) has a critical role during development of the retina. We
investigated RA effects on photoreceptor apoptosis and differentiation, and the intracellular
pathways involved.
METHODS. Rat retinal neuronal cultures were supplemented with RA with or without
docosahexaenoic acid (DHA), a photoreceptor survival factor, and photoreceptor apoptosis
and differentiation were evaluated at different times of development. To investigate the
intracellular pathways activated by RA, the levels of phosphorylated (P) ERK and P-p38 in
cultures with or without RA, and the effect of pretreatment with SB203580, a p38 specific
inhibitor, on apoptosis and differentiation were evaluated.
RESULTS. RA addition at day 0, when cells still were proliferating, selectively increased
apoptosis in photoreceptors, whereas addition at day 2 no longer caused cell death. RA
stimulated opsin and peripherin expression, and neurite outgrowth regardless of the time of
development. Addition of RA at day 0, but not at day 2, rapidly increased P-p38 levels, but did
not affect P-ERK levels. p38 inhibition completely prevented RA-induced apoptosis, and
partially decreased differentiation. DHA prevented apoptosis and additively increased
differentiation, without affecting RA activation of p38.
CONCLUSIONS. Our results show that RA activation of the p38 intracellular pathway was
essential for its early induction of apoptosis and partially responsible for promoting
differentiation. DHA prevention of this apoptosis suggests that RA effects during early
development must be counterbalanced by survival factors to prevent photoreceptor death, in
an interplay that might help to establish the final number of photoreceptors.
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Apoptosis is an integral part of development. Of the hugesurplus of cells generated during development of the
nervous system, those that fail to establish adequate connec-
tions and get survival signals die through apoptosis, which
contributes to sculpting a functional system. In the retina, after
synaptogenesis, photoreceptors need several survival and
trophic factors to prevent this apoptosis and continue their
development.1,2 Similarly, in cultures lacking trophic factors,
photoreceptors start to degenerate and die after 4 days in vitro,
following an apoptotic pathway.3 Photoreceptor trophic
factors, such as glial derived neurotrophic factor (GDNF), basic
fibroblast growth factor (FGFb), ciliary neurotrophic factor
(CNTF), and docosahexaenoic acid (DHA) are required to
promote photoreceptor survival in vivo and in vitro.3–8
Another set of signaling molecules, such as taurine and all-
trans-retinoic acid (atRA), act earlier in development.9,10 RA is a
crucial inducer of differentiation in many cell types, among
them retina neurons.11–14 It has a critical role during the
development of photoreceptors in vivo and in vitro,10,15
determining cell fate and promoting opsin expression.16,17
Photoreceptor trophic factors, such as FGFb, GDNF, and
DHA, have their pro-survival actions coupled to an advance-
ment of differentiation, which seems reasonable for establish-
ing a mature, functional system.3,6,8,18 This appears not to be
the case for RA, which triggers apoptosis of NT2 cells, a human
teratocarcinoma cell line, when inducing their differentiation to
a neuronal phenotype.19,20 In mouse retinal explants 9-cis-RA
induces photoreceptor apoptosis, simultaneously increasing
opsin expression.17
Though known to modulate numerous signaling pathways
in different cell types, the intracellular pathways activated by
RA to achieve its effects on photoreceptors remain to be
established. To investigate them, we have used pure neuronal
cultures from neonatal rat retinas, which initially present retina
progenitors that later differentiate as amacrine and photore-
ceptor cells. This allows us to evaluate the effects of RA on
photoreceptor differentiation and apoptosis. Our results
showed that RA rapidly advanced the differentiation of
photoreceptors at different times of development, but only
induced their early apoptosis if added when cells still were
cycling. They also evidenced that RA effects on photoreceptor
apoptosis depended on the activation of the p38 MAP kinase
(p38 MAPK) signaling pathway, whereas differentiation in-
volved this mechanism together with other signaling pathways.
DHA, a photoreceptor survival molecule, prevented RA-
induced apoptosis and had an additive effect on differentiation.
Our results suggested that a fine balance between the levels of
RA and those of survival molecules is indispensable during
development to promote differentiation and simultaneously
preserve the adequate number of photoreceptors in the retina.
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MATERIALS AND METHODS
Albino Wistar rats bred in our own colony were used in all
experiments. All proceedings concerning animal use were
done in accordance with the ARVO Statement for the Use of
Animals in Ophthalmic and Vision Research, and the guidelines
published in the NIH Guide for the Care and Use of
Laboratory Animals (available in the public domain at
http://grants.nih.gov/grants/olaw/Guide-for-the-Care-and-Use-
of-Laboratory-Animals.pdf). Plastic culture dishes (CellStar)
were from Greiner Bio-One (Frickenhausen, Germany). Dul-
becco’s modified Eagle’s medium (DMEM; Gibco) was pur-
chased from Life Technologies (Grand Island, NY). All-trans
retinoic acid (98% purity by HPLC), poly-L-ornithine, trypsin,
trypsin inhibitor, transferrin, hydrocortisone, putrescine,
insulin, CDP-choline, CDP-ethanolamine, gentamicin, 4,6-dia-
midino-2-phenylindole (DAPI), paraformaldehyde, (4-[40-fluo-
rophenyl]-2-[4 0-methylsulfinylphenyl]-5-[4 0-pyridyl] imidazole,
SB203580), DHA, monoclonal anti–acetylated tubulin and
anti-syntaxin (HPC-1) antibodies were from Sigma-Aldrich (St.
Louis, MO). Polyclonal antibodies against P-p38, total p38, P-
Erk1-2, and total Erk1-2 were from Cell Signaling Technologies
(Beverly, MA). Monoclonal antibodies against rhodopsin
(Rho4D2) and peripherin (clone p3b6) were generously
supplied by Robert Molday (University of British Columbia,
Vancouver, BC, Canada). Polyclonal anti-Crx antibody was a
generous gift of Dr Cheryl Craft (University of Southern
California, Los Angeles, CA). Polyclonal anti-Pax6 antibody was
a kind gift of Dr GS Mastick (University of Michigan, Ann Arbor,
MI). Cy2 and Cy3 conjugated goat anti-rabbit secondary
antibodies were from Jackson ImmunoResearch (West Grove,
PA).
Monoclonal antibodies anti–actin, nestin, p27kip1, and
secondary antibodies used for Western Blot analysis, goat
anti–mouse IgG-horseradish peroxidase (HRP), and goat anti–
rabbit IgG-HRP, were from Santa Cruz Biotechnology, Inc.
(Santa Cruz, CA). Tyramide Signal Amplification kit (TSA) was
from DuPont NEN (Wilmington, Denmark). Monoclonal
antibody against BrdU (clone G3G4) was from DSHB (devel-
oped under the auspices of the NICHD and maintained by the
University of Iowa, Department of Biological Sciences, Iowa
City, IA). MitoTracker Red CMXRos and terminal deoxynucleo-
tidyl transferase, recombinant 5-bromo-2-deoxyuridine-5-tri-
phosphate (BrdUTP), and terminal deoxy-nucleotidyl
transferase (TdT) buffer were from Molecular Probes (Eugene,
OR). Cell-permeant pan caspase inhibitor, carbobenzoxy-valyl-
alanyl-aspartyl-(O-methyl)-fluoromethylketone (Z-VAD-FMK)
was from Promega (Madison, WI). Polyvinylidene difluoride
(PVDF) membranes were Immobilon P (Millipore, Billerica,
MA). Solvents were HPLC grade, and all other reagents were
analytical grade.
Neuronal Cultures
Pure neuronal cultures were obtained from 0- or 2-day-old
(PN0-2) rat retinas as described previously.3 In brief, retinas
were dissected and dissociated under mechanical and chemical
digestion with 0.25% trypsin. Cells then were resuspended and
seeded in a chemically defined medium,3,21 in dishes pretreat-
ed sequentially with poly-L-Ornithine and Schwannoma condi-
tioned medium.22 Cultures were incubated at 368C in a 5% CO2
atmosphere. Retinal progenitors differentiated mainly into
amacrine neurons and rod photoreceptors, which amounted
to approximately 30% and 70% of total cells, respectively.
Occasionally, a few glial cells were observed (less than 1% of
total cells), which did not proliferate due to the high adhesive
substrata, low cell density, and lack of serum. Neuronal cell
types were identified by their morphology, using phase-
contrast microscopy and by immunocytochemistry, using the
monoclonal antibodies anti-syntaxin (HPC-1) and Rho4D2, for
amacrine and photoreceptor neurons, respectively.23–25 Pho-
toreceptors have a small round cell body (3–5 lm in diameter)
with a single neurite, which usually ends in a conspicuous
synaptic ‘‘spherule’’; sometimes they display a connecting
cilium at the opposite end, but they fail to develop their
characteristic outer segments; opsin is distributed diffusely
over their cell body, which usually is darker than that of
amacrine neurons. To be identified as photoreceptors, the cells
had to display at least three of the above described criteria.
Amacrine neurons are larger than photoreceptors (7–20 lm in
diameter) and have multiple neurites. Almost all of them show
HPC-1 immunoreactivity starting at early stages of develop-
ment, which is retained even after undergoing degenerative
changes that alter their morphologic appearance.26
Addition of RA
Stock solutions of all-trans RA (1 mM in absolute ethanol,
EtOH) were prepared, maintained in the dark at 708C, and
diluted further in DMEM at the time of supplementation;
aliquots were added under dim light to reduce RA degradation.
RA was added 1 hour after seeding the cells, or at day 2. To
establish the effect of different concentrations of RA on
differentiation and apoptosis, dilutions ranging from 106 to
109 M were used. In every case, EtOH concentration was
below 0.01% (final concentration in culture). The same EtOH
concentration was added to control cultures.
Addition of DHA
DHA (6.7 lm final concentration in culture) was added at day
0, in a complex with BSA.3 A BSA solution was added to control
cultures.
Evaluation of Proliferation and Cell Fate
To assess proliferation, cultures from PN0 retinas were treated
with or without RA at day 0, incubated for 4 hours with 30 lM
BrdU (final concentration in culture), and fixed after 12 or 48
hours in vitro with 4% paraformaldehyde. BrdU uptake was
determined using a monoclonal antibody against BrdU.
To determine the number of proliferating progenitors we
evaluated (1) the expression of the neuroectoderm marker,
nestin; (2) the expression of the cell cycle blocker, p27kip1; and
(3) the percentage of cells expressing Pax6 during the first 48
hours after RA addition. Though Pax6 is expressed in every
mitotic retina progenitor,27 its expression only remains in
postmitotic amacrine neurons. To evaluate proliferation
exclusively, we excluded cells that coexpressed HPC-1, an
amacrine cell marker, and Pax6. To analyze RA effect on cell
fate, we determined the amount of cells expressing Crx, a
photoreceptor marker, and HPC-1 after 24 or 48 hours in vitro,
using specific monoclonal antibodies.
Activation of the p38 MAPK Pathway
To establish whether the activation of the p38 MAPK pathway
was involved in RA effects on apoptosis and differentiation,
SB203580, a specific, cell permeant inhibitor of p38, was used.
A stock solution was prepared in DMSO and diluted in DMEM
before addition to the cultures (100 nM, final concentration in
culture). To analyze whether RA promoted the phosphoryla-
tion of p38, cells were treated with RA or vehicle at days 0 and
2, and either fixed or scraped for immunocytochemical or
Western blot analyses, using a polyclonal antibody against
phosphorylated (P)-p38.
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Activation of the ERK/MAPK Pathway
To investigate whether RA modulated the ERK/MAPK pathway,
cells were treated with RA or vehicle at day 0, and either fixed
or scraped for immunocytochemical or Western Blot analyses.
P- and total ERK were determined using polyclonal antibodies.
Immunocytochemical Methods
Cultures were fixed with 4% paraformaldehyde in PBS, for at
least 30 minutes at room temperature, followed by perme-
ation with Triton X-100 (0.1% in PBS). For immunocytochem-
istry, Cy2 and Cy3-conjugated goat anti-mouse or anti-rabbit
were used as secondary antibodies. TSA occasionally was
used to improve visualization. Controls were performed by
omitting either the primary or the secondary antibodies.
Cultures were analyzed by phase contrast and fluorescence
microscopy.
Evaluation of Photoreceptor Differentiation
To evaluate whether RA advanced the differentiation of
photoreceptors, we determined the amount of cells expressing
opsin, the visual pigment, and peripherin, a disk membrane
protein, and the amount of photoreceptors having either
opsin- or peripherin-positive apical processes, using Rho4D2
and anti-peripherin monoclonal antibodies, respectively.
Analysis of Neurite Outgrowth
Neurites were labeled with an anti a-acetylated tubulin
antibody. To distinguish between photoreceptor and amacrine
cell neurites, we determined the number of neurons coex-
pressing a-acetylated tubulin with either Crx or HPC-1,
respectively. To assess neurite outgrowth we evaluated the
amount of neurons bearing long neurites, defined as those
whose length exceeded 3 and 4 cell body diameters, for
photoreceptors and amacrine cells, respectively.
FIGURE 1. Effect of RA on cell survival. Neuronal cultures were treated with vehicle (EtOH, control, [A–C]), RA (D–F), RA and DHA (in a BSA
solution, [G–I]), the pan-caspase inhibitor Z-VAD-FMK (ZVAD, [J–L]), or the p38MAPK specific inhibitor SB203580 (SB, [M–O]) at day 0, and
apoptosis was evaluated at day 3. Phase contrast (A, D, G, J, M) and fluorescence (B, C, E, F, H, I, K, L, N, O) photomicrographs show that RA
induced apoptosis in photoreceptors, as evidenced by the increase in the amount of pyknotic nuclei (nuclei with condensed and bright DAPI
staining, arrowheads) and TUNEL-positive cells, as compared to control cultures. Pretreatment with either DHA (G–I), Z-VAD (J–L), or SB (M–O)
reduced RA-induced apoptosis. The effect of increasing concentrations of RA on photoreceptor apoptosis is shown in (P). Quantification of the
percentage of apoptotic photoreceptors (Q), by analyzing nuclei integrity with DAPI, showed a significant increase in apoptosis in RA-treated
cultures, and the protective effect of DHA, and the p38 and pan-caspase inhibitors. The effect of RA addition at days 0 and 2 in culture on
photoreceptor apoptosis is compared in (R); RA only induced apoptosis when added at day 0. *P < 0.05. Scale bar: 15 lm.
Retinoic Acid Activates p38 MAPK in Photoreceptors IOVS j May 2013 j Vol. 54 j No. 5 j 3145
Evaluation of Apoptosis
Apoptosis was determined by evaluation of nuclei integrity and
by TUNEL assay.28 Nuclear integrity was evaluated by staining
cell nuclei with DAPI; neurons were considered apoptotic
when they showed either fragmented or condensed (pyknotic)
nuclei. The number of apoptotic photoreceptors and amacrine
cells was determined in cultures double-labeled with DAPI and
Rho4D2 or HPC-1, respectively.
To investigate whether RA induced apoptosis through a
caspase-dependent pathway, day 0 cultures were treated with a
cell-permeant, pan-caspase inhibitor, Z-VAD-FMK, in DMEM (20
lM, final medium concentration) and one hour later with or
without RA. Apoptosis was determined at day 3, by evaluating
nuclei integrity.
Evaluation of Mitochondrial Membrane Potential
Changes in mitochondrial membrane potential were analyzed
by incubating cultures for 20 minutes before fixation with the
fluorescent probe MitoTracker Red (0.1 mg/mL), which labels
mitochondria retaining their membrane potential with a bright
red fluorescence.
Microscopy
Cultures were analyzed by phase contrast and epifluorescence
microscopy, using a Nikon Eclipse E600 microscope with a C-C
Phase Contrast Turret Condenser and a Y-FL Epi-Fluorescence
Attachment (Nikon Instruments, Inc., Mellville, NY), and a
laser scanning confocal microscope (Leica DMIRE2; Leica
Microsystems, Wetzler, Germany) with a 63X water objective;
images were collected and processed with LCS software (Leica
Microsystems) and Photoshop 8.0 (Adobe Systems, San Jose,
CA).
Western Blotting
Western blot was performed to investigate protein expres-
sion.29 Proteins were quantified (DC, Bio-Rad; Hercules, CA),
subjected to one-dimensional electrophoresis,30 transferred to
PVDF membranes, and visualized with enhanced chemilumi-
nescence (ECL Plus Western Blotting Detection Reagents - RPN
2132; GE Healthcare, Silver Spring, MD). Images were obtained
by scanning at 600 dpi and bands were quantified with ImageJ
software (NIH).
Statistical Analysis
For cytochemical studies, 10 fields per sample, randomly
chosen, were analyzed in each case. Each value represented
the average of at least three experiments, with three to four
dishes for each condition 6 SD. Statistical significance was
determined by Student’s 2-tailed t-test.
RESULTS
RA-Induced Photoreceptor Apoptosis
We first evaluated the effect of RA addition at day 0 on cell
death. By day 3, cultures lacking RA showed virtually no
TUNEL-positive cells, and approximately 6% of photoreceptors
had fragmented or pyknotic nuclei (Figs. 1A–C, 1P, 1Q).
Addition of 107 M RA increased this percentage to approx-
imately 16%. Since 109 M and 108 M RA induced a slight,
though nonsignificant, increase in apoptosis (Fig. 1P) and
higher (106 M) RA concentrations provoked morphologic
changes (abnormal cell morphology and neurite fragmentation
and cell detachment, not shown), 107 M RA was used in
subsequent experiments.
To investigate whether time of development in vitro
influenced RA-induced apoptosis of photoreceptors, RA was
added at day 0 or 2. At day 3, controls showed very few
FIGURE 2. Effect of RA on mitochondrial membrane potential.
Cultures were treated at day 0 with or without RA, and
mitochondrial membrane potential (A, C, E) and nuclei integrity
(B, D, F) were evaluated after 3 days in vitro, using MitoTracker and
DAPI, respectively. Fluorescence photomicrographs show control
cultures (A, B) had more photoreceptors preserving mitochondrial
membrane potential (bright localized fluorescence in [A], arrows)
than RA-treated cultures (C, D), which showed unlocalized dim
fluorescence ([C], arrowheads). Treatment with the p38 inhibitor
SB203580 before RA addition (E, F) prevented RA-induced mito-
chondrial membrane depolarization ([E], arrows). The percentage
of photoreceptors preserving mitochondrial membrane potential is
shown in (G); note that RA significantly decreased the amount of
photoreceptors having active mitochondria, while pretreatment
with DHA and SB203580 prevented this decrease. *P < 0.05. Scale
bar: 15 lm.
TABLE 1. Effect Of RA on Amacrine Cell Survival
Treatment Apoptotic Cells, % Active Mitochondria, %
EtOH 1.5 6 0.3 93.8 6 2.8
RA 1.7 6 0.1 94.8 6 1.5
The percentage of apoptotic amacrine neurons and of amacrine
neurons preserving their mitochondrial membrane potential at day 3
was determined by immunocytochemistry using DAPI and Mitotracker,
respectively.
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FIGURE 3. Activation of p38 MAPK by RA. Phase contrast (A, C) and fluorescence (B, D) photomicrographs show expression of P-p38 in control (A,
B) and RA-treated cultures (C, D) analyzed by immunocytochemistry at day 0. RA markedly increased P-p38 levels (note P-p38 labeled cells in [D],
almost absent in [B]), particularly in photoreceptors (arrowheads in [D]). Western blots (lower panel) and relative changes in P-p38 expression
(upper panel) at different times of incubation with RA, DHA, RA plus DHA, or EtOH added at day 0 are shown in (E). RA induced a rapid increase in
P-p38 levels between 1 and 4 hours after treatment, which decreased to control levels after 24 hours. Note that DHA addition neither
elicited a p38 response nor blocked the RA-induced increase in P-p38, thus suggesting that DHA activated a different signaling pathway. Western
blots (lower panel) and relative changes in P-p38 expression (upper panel) in cultures treated without or with RA, added at day 2 are shown in (F);
note that at this time point RA no longer induced p38 activation. *P < 0.05. Scale bar: 15 lm.
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apoptotic cells, as photoreceptor degeneration had not yet
started4 (Figs. 1A–C). RA addition at day 0, when many
photoreceptor precursors still are active in the cell cycle,27,31
induced a premature onset of apoptosis; TUNEL-positive cells
clearly were evident (Figs. 1D–F) and the percentage of
photoreceptors showing pyknotic nuclei increased from
approximately 6% in controls to 14.8% after RA treatment
(Fig. 1Q).
In contrast, RA addition by day 2, when most cells have
exited the cell cycle,27 did not increase photoreceptor
apoptosis. By day 4, the percentage of apoptotic photorecep-
tors in RA-treated cultures showed no significant differences
compared to controls (Fig. 1R).
Pretreatment with Z-VAD-FMK, a pan-caspase inhibitor,
before RA supplementation completely blocked RA-induced
apoptosis (Figs. 1J–L, 1Q). This apoptotic pathway involved
mitochondrial membrane depolarization. At day 1, approxi-
mately 70% of photoreceptors preserved their mitochondrial
membrane potential, with or without RA (not shown). By day
3, RA decreased the amount of photoreceptors preserving
mitochondrial polarization (Figs. 2C, 2D, 2G). While approx-
imately 60% of photoreceptors retained their mitochondrial
membrane potential in controls (Figs. 2A, 2B, 2G), this
percentage decreased to 39.5% in RA-treated cultures (Fig. 2G).
RA-Induced Cell Death was Selective for
Photoreceptors
RA selectively induced photoreceptor apoptosis. Apoptotic
amacrine cells in 3-day cultures were approximately 1.5%, with
or without RA, and showed no statistical differences at later
times in vitro (Table 1). Consistently, the percentages of
amacrine neurons preserving mitochondrial membrane poten-
tial were very similar in control and RA-treated cultures (Table
1).
RA Activated the p38 Signaling Pathway in
Photoreceptors
RA has been shown to activate p38 MAPK, a stress-responsive
serine kinase that is linked to regulation of apoptosis in several
cell types.32–37 To investigate whether RA activated p38 MAPK
in photoreceptors, we evaluated the levels of P-p38, its active
form. RA addition at day 0 visibly increased P-p38 expression,
compared to controls, mainly in photoreceptors (arrows in
Figs. 3C, 3D). The increase was very rapid; Western Blot
analysis revealed higher levels of P-p38, compared to controls,
1 hour after adding RA (Fig. 3E), and increments of
approximately 40% and 30% in the P-p38/p38 ratio 2 and 4
hours after RA addition (Fig. 3E). This increase was transient, as
24 hours after RA addition P-p38 levels were similar to those in
controls (Fig. 3E). Noteworthy, RA addition at day 2 in vitro,
which did not induce apoptosis, did not increase P-p38 levels
(Fig. 3F).
Pretreatment with the p38 inhibitor SB203580 almost
completely prevented RA-induced apoptosis; the amount of
TUNEL-positive cells was markedly reduced (Figs. 1M–O) and
apoptotic photoreceptors decreased from 14.8% in RA-treated
cultures to approximately 5% in cultures with SB203580 and
RA (Fig. 1Q). Mitochondrial membrane potential, which was
preserved in 80% of photoreceptors in cultures with SB203580
and lacking RA, was reduced to 39.5% with RA addition (Fig.
2G), but almost completely preserved in cultures pretreated
with SB203580 before RA addition (Figs. 2E, 2F). These results
imply that RA activation of the p38MAPK pathway is crucial to
induce photoreceptor apoptosis.
Since DHA and FGF activate the ERK/MAPK pathway to
promote photoreceptor survival,6,38 we investigated whether
RA modulated this pathway to trigger apoptosis. No significant
differences were observed in P-ERK labeling between controls
and RA-treated cultures at day 1 (Figs. 4A–D). Western Blot
analysis evidenced no increase either in P-ERK or in the P-ERK/
ERK ratio, compared to controls, after 1, 2, 4, and 24 hours of
RA addition to day 0 cultures (Fig. 4E).
DHA Prevented RA-Induced Apoptosis
We found intriguing that RA, which is essential for retina
development, concurrently triggered cell death in developing
photoreceptor progenitors. This implied that survival mole-
cules should be present at the same time of development to
counteract RA pro-apoptotic effect. Since photoreceptors
depend on several trophic and survival molecules to prevent
apoptosis, including DHA,4,38–42 we evaluated RA effect on
photoreceptor apoptosis in cultures without or with DHA. By
day 3, RA significantly increased photoreceptor apoptosis,
compared to controls (Figs. 1B, 1C, 1E, 1F), but supplemen-
tation with DHA before RA addition completely prevented this
increase (Figs. 1G–I, 1Q). DHA also prevented RA-induced
mitochondrial membrane depolarization; approximately 39.5%
FIGURE 4. Effect of RA on ERK/MAPK signaling. Day 0 control (A, B)
and RA-treated cultures (C, D) were incubated for different times after
RA addition and then cells were fixed for immunocytochemical
analysis, using a polyclonal phosphorylated P-ERK1-2 antibody, or
scraped for Western blot analysis, using anti P-ERK or anti total ERK
antibodies. Phase contrast (A, C) and fluorescence (B, D) photomi-
crographs show P-ERK labeled cells in control (A, B) and RA-treated (C,
D) cultures, 24 hours after RA supplementation; note that RA did not
affect P-ERK labeling (compare [A–D]). Western blots (E) of P-ERK
after 1, 2, 4, and 24 hours of RA treatment evidenced no significant
differences between controls and RA-supplemented cultures. Scale
bar: 15 lm.
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of photoreceptors preserved their mitochondrial potential in
RA-treated cultures, whereas in those pretreated with DHA this
value was 67.5%, almost as in controls (Fig. 2G).
We then investigated whether DHA inhibited RA induction
of apoptosis by blocking p38 activation. Pretreatment with
DHA at day 0 did not preclude the increase in P-p38 levels
induced by RA 1 to 4 hours after its addition (Fig. 3E). Hence,
DHA protection of photoreceptors did not entail inactivation
of p38 phosphorylation.
RA Promoted the Simultaneous Activation of
Apoptosis and Differentiation in Photoreceptors
Since RA is known to promote photoreceptor differentia-
tion,10,15,43–45 we investigated whether its addition at day 0,
which prompted apoptosis, simultaneously activated differen-
tiation. Retina photoreceptors cultured in media lacking their
trophic factors develop as round cells with a small cell body
and a short cilium,3,4 and usually lack the high opsin levels and
characteristic outer segments found in photoreceptors in vivo.
Addition of RA at day 0 increased opsin expression (Figs. 5C,
5D), being most effective at 107 M (not shown).
RA stimulation of opsin expression augmented during time
in vitro. A small increase already was observed in RA-
supplemented cultures at day 2 (Fig. 5E) and opsin-expressing
photoreceptors increased from 4.1% to 11.1% at day 4, from
16% to 37% at day 6, and from 22.3% to nearly 53%, at day 9 in
controls and RA-supplemented cultures, respectively. This
increase was confirmed by Western Blot (Fig. 5F).
RA increased the number of photoreceptors expressing
peripherin/rds, a structural protein of the rims of outer
segment discs, essential for their correct folding and mainte-
nance (Figs. 6A–D). This protein accumulated in apical
processes, structures that resemble the first steps of outer
segment development (Figs. 6C, 6E, arrowheads). RA effect on
peripherin expression was higher at early times in vitro; RA
doubled the amount of cells expressing peripherin by day 4,
whereas they increased 30% by day 6 (Fig. 6F). Western Blot
analysis confirmed this increase (not shown). RA also induced
the formation of peripherin-labeled cilia and apical processes
(Figs. 6C–E, arrowheads). The number of cells that developed
peripherin-positive cilia and apical processes increased from
approximately 15,000 cells/dish in controls to nearly 22,000
cells/dish in RA-supplemented cultures (Fig. 6G). As a whole,
these results support that addition of RA when photoreceptor
progenitors still were cycling simultaneously induced their
differentiation and apoptosis.
RA addition at day 2, when cell proliferation was over and
RA no longer triggered apoptosis, increased opsin-positive
photoreceptors from 6.2% in controls to 14.9% in RA-
supplemented cultures at day 4 (Fig. 5G). This implies that
RA enhanced photoreceptor differentiation independently of
the presence of proliferating cells.
We then investigated whether inhibiting RA-induced
apoptosis with Z-VAD-FMK increased photoreceptor differen-
tiation after RA addition. RA doubled the percentage of opsin-
FIGURE 5. Effect of RA on opsin expression. Cultures prepared from
retinas from PN2 rats were supplemented with (107) M RA, or with
vehicle (EtOH) 1 hour after plating. Fluorescence (A, C) and phase
contrast (B, D) photomicrographs of 6-day old cultures show the
increase in opsin expression (green) in RA-treated cultures (C, D)
compared to controls (A, B). Changes in the percentages of opsin-
expressing photoreceptors at different times of development are
shown in (E). Western Blots show the increase in opsin levels in 6-day
cultures treated with 107 M RA at day 0 (F). The percentage of
photoreceptors expressing opsin at day 4 in cultures treated without or
with RA at day 2 is shown in (G); note that RA added at this time in
vitro also increased opsin expression. Changes in the percentage of
photoreceptors expressing opsin in control cultures; cultures treated
at day 0 with RA; RA plus vehicle (DMSO) or the p38 inhibitor
SB203580 are shown (H). Note that SB203580 only partially blocked
RA effect on opsin expression. *P < 0.05. Scale bar: 15 lm.
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positive photoreceptors, compared to controls cultures, but
pretreatment with Z-VAD-FMK did not affect this increase
(Table 2). This suggested that RA promoted the differentiation
of a specific pool of photoreceptors and increasing photore-
ceptor survival did not augment this pool.
RA Effects on Opsin Expression Depended on p38
Activation
We then evaluated whether p38 activation also was involved in
RA effects on differentiation. Without SB203580, RA increased
opsin-positive photoreceptors from approximately 5% to 10.4%
at day 6; addition of SB203580 at day 0 reduced RA
enhancement of opsin expression (Fig. 5H), but did not block
it completely. This suggested that activation of p38 is one, but
not the only, pathway involved in RA effect on differentiation.
Additive Effects of DHA and RA on Photoreceptor
Differentiation
As DHA promotes photoreceptor differentiation,18 we ex-
plored whether its addition with RA had an additive or
synergistic effect on this differentiation. At day 6 the
percentage of opsin-positive cells increased from approximate-
ly 6% in controls to 16% and 12% in cultures with RA or DHA,
respectively. Noteworthy, their combined addition led to an
increment of approximately 30%, which amounted to the sum
of separate effects (Fig. 7A). RA and DHA showed a similar
additive effect on peripherin expression (Fig. 7B).
RA Promoted Neurite Outgrowth
We then evaluated RA effect on neurite outgrowth. In controls,
most photoreceptors developed short neurites (Figs. 8A–C), as
TABLE 2. Effect of RA-Induced Apoptosis Inhibition on Photoreceptor
Differentiation
Treatment Opsin þ
EtOH 5.9 6 1.3
ZVAD-FMK 6.2 6 1.0
EtOH þ ZVAD-FMK 7.6 6 3.3
RA 16.3 6 1.6
RA þ ZVAD-FMK 15.3 6 4.6
The percentage of opsin-positive photoreceptors at day 3 in vitro
was determined in cultures treated with or without RA, and with or
without the pan-caspase inhibitor ZVAD-FMK.
FIGURE 7. Additive effects of RA and DHA on photoreceptor
differentiation. The percentages of photoreceptors expressing opsin
(A) and peripherin (B) were analyzed in 6 day-cultures supplemented
at day 0 with RA, DHA, their vehicles (EtOH and BSA, respectively), or
RA plus DHA. While RA and DHA, added separately, increased the
percentages of opsin (A) and peripherin (B) expressing photorecep-
tors, their combined addition induced a higher increase suggesting an
additive effect of RA and DHA on photoreceptor differentiation. *P <
0.05.
FIGURE 6. Effect of RA on peripherin expression and formation of
apical processes. Neuronal cultures were supplemented at day 0
without or with RA, and peripherin expression at days 4 and 6 was
evaluated with an anti-peripherin monoclonal antibody. Phase contrast
(B, D) and fluorescence (A, C, E) photomicrographs of 6-day cultures
show that RA (C, D) increased the amount of photoreceptors
expressing peripherin (arrows) compared to controls (A, B). The
relative increase in peripherin expression in RA-supplemented
cultures, compared to controls, is shown (F). RA also increased the
amount of photoreceptors (G) that developed apical processes
(arrowheads in [C], [D] and [E]) compared to controls. *P < 0.05.
Scale bar: 15 lm.
Retinoic Acid Activates p38 MAPK in Photoreceptors IOVS j May 2013 j Vol. 54 j No. 5 j 3150
evidenced by a-acetylated tubulin labeling. RA significantly
increased the sprouting and outgrowth of neurites; the number
of photoreceptors having neurites (Fig. 8G) and bearing long
neurites (i.e., >3 body diameters, Figs. 8D–F, 8G) was higher in
RA-treated cultures than in controls. This effect was time
dependent; while at day 2 RA had no effect, by day 6 the
percentage of photoreceptors having long neurites increased
from 9.9% in controls to 19.7%, in RA-treated cultures (Fig. 8G).
RA also promoted neurite outgrowth in amacrine cells (Figs.
8H–K). By day 6, the percentage of these cells having long
neurites (i.e., >4 body diameters) increased from 17.2% in
controls to 34.1% in RA-treated cultures (Fig. 8L).
We then analyzed whether RA activated the p38 MAPK
pathway to enhance neurite outgrowth. By day 6, approxi-
mately 30% of amacrine neurons and 27% of photoreceptors
had long neurites in RA-supplemented cultures, and pretreat-
ment with SB203580 before RA supplementation did not
decrease these percentages (Table 3).
RA Effect on Cell Cycle Exit
We investigated whether RA advanced differentiation of
photoreceptors by promoting an earlier exit of their progen-
itors from the cell cycle. Cultures from PN0 retinas treated at
day 2 with or without RA showed similar percentages of BrdU-
positive cells (Table 4). Since by day 2 few photoreceptor
progenitors remain in the cell cycle, we added RA at day 0,
when many progenitors still are proliferating46; this addition
decreased slightly, though not significantly, the percentage of
BrdU-labeled cells compared to controls (Table 4).
Similarly, RA decreased slightly, though not significantly, the
percentage of cells expressing nestin, a neuroectoderm marker
FIGURE 8. Effect of RA on neurite outgrowth. Cultures prepared from PN2 pups were treated with RA at day 0, and neurite outgrowth was
evaluated at days 2 and 6, in photoreceptors, and 6 in amacrine cells. Fluorescence photomicrographs (A–F) of 6-day cultures show neurites in
photoreceptors, identified by double-labeling with anti-CRX ([A, D], red) and anti-acetylated tubulin ([B, C, E, F], green) antibodies. RA-
supplemented cultures (D–F) showed more photoreceptors having long neurites than controls (A–C). The percentage of photoreceptors having
processes and of those having long processes (>3 body diameters) in cultures without and with RA is shown (G). Phase contrast (H, J) and
fluorescence (I, K) photomicrographs of 6-day cultures show amacrine cells had longer neurites in RA-treated cultures (J, K) than in controls (H, I).
The percentage of amacrine cells having long processes (>4 body diameters) is shown in (L). *P < 0.05. Scale bar: 15 lm.
TABLE 3. Effect of p38 Inhibition on Neurite Outgrowth
Treatment
Amacrine Cells
Having Long
Neurites, %
Photoreceptors
Having Long
Neurites, %
EtOH 14.2 6 0.9 14.0 6 2.8
DMSO 14.6 6 2.2 15.2 6 3.1
SB203580 15.1 6 9.4 13.0 6 1.7
RA 29.3 6 1.6 26.9 6 4.0
RA þ SB203580 30.3 6 3.0 29.4 6 7.1
Percentage of amacrine and photoreceptor neurons bearing long
neurites (>4 and 3 body diameters, respectively) in 6-day cultures
treated at day 0 with RA, vehicle (EtOH), the p38 inhibitor (SB203580),
its vehicle (DMSO), RA, or pretreated with SB203580 and 30 minutes
later with RA (RA þ SB203580, N¼ 3).
TABLE 4. Effects of RA on Proliferation
Days
In Vitro Treatment BrdU/Total Cell N, %
0 EtOH 17.5 6 4.6
RA 16.1 6 3.2
2 EtOH 2.9 6 2.5
RA 3.6 6 1.9
Retinal cell cultures prepared from PN0 retinas were treated with
vehicle (EtOH) or with RA at day 0 and pulse-labeled with BrdU for 4
hours before fixation after 12 or 48 hours in vitro. The percentage of
BrdU-positive cells was determined by immunocytochemistry.
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present in proliferating cells, after 12 and 24 hours in culture.
RA simultaneously induced a small, nonsignificant increase in
cells expressing p27kip1, a cell cycle inhibitor expressed by
photoreceptors when exiting the cell cycle, compared to
controls (Table 5).
Pax6 expression is present in all multipotent retinal
progenitors27,29,47–49; it is lost in post mitotic photoreceptors,
but it is preserved in amacrine cells. The percentage of cells
that only expressed Pax6, excluding those double-labeled with
HPC-1 and Pax6, that is, amacrine cells, decreased significantly
between 12 and 48 hours after seeding the cells, reflecting the
exit of photoreceptor progenitors from the cell cycle,27 and
was unaffected by RA (Table 5). These results showed a
tendency, but not a significant effect of RA on inducing an
earlier cell cycle exit of photoreceptor progenitors.
We also investigated whether RA added at day 0 influenced
cell fate or an early differentiation as photoreceptors of retinal
progenitors. RA increased slightly, though not significantly, the
percentage of cells expressing Crx, an early photoreceptor
marker, compared to controls at day 1 and had no effect at day
2 (Table 6). The percentage of HPC-1–positive cells remained
unchanged. This suggested that RA did not induce photore-
ceptor cell fate at this time in vitro.
DISCUSSION
RA is known to induce apoptosis and differentiation in diverse
tissues, including the retina.10,11,50–52 We showed here that RA
selectively promoted cell death and differentiation in retina
photoreceptors. RA only induced an early onset of apoptosis
when retinal progenitors still were in the cell cycle, whereas it
advanced photoreceptor differentiation independently of the
presence of proliferating progenitors. RA activation of the p38
MAPK signaling cascade was crucial for its induction of
photoreceptor apoptosis; RA only activated this pathway at
early developmental times and inhibiting this activation
completely blocked its apoptotic effect. RA effect on photore-
ceptor differentiation also was dependent, though not exclu-
sively, on the activation of the p38 MAPK pathway. Finally, our
data showed that DHA, a trophic factor for photoreceptors,
prevented RA-induced apoptosis and promoted an additive
enhancement of differentiation in photoreceptors. A schematic
summary of these findings is shown in Figure 9.
In the absence of trophic factors, photoreceptors start
degenerating after 4 days in culture through an apoptotic
pathway involving caspase activation and loss of mitochondrial
membrane potential.4,38 We showed here that, if added while
photoreceptor progenitors still were active in the cell cycle, RA
induced a premature cell death in photoreceptors through a
similar apoptotic pathway, promoting mitochondrial depolar-
ization and caspase activation. Noteworthy, RA addition when
cells had exited the cell cycle no longer induced apoptosis (Fig.
9). RA has been shown to induce apoptosis in parallel with
differentiation in undifferentiated cells, at a time that concurs
with the onset of their neuronal phenotype, as occurs in the
NT2 neuronal cell line.20 If RA forceful induction of
differentiation in retinal progenitors when still immature is
responsible of activating their apoptosis, we should expect RA
to decrease proliferation and promote the early achievement of
a photoreceptor cell fate as well. In rodents, many progenitor
cells remain mitotically active until postnatal days 3 to 5, and in
neuronal cultures from PN0 rat pups, these progenitors have
their last mitotic divisions in vitro, with most of them adopting
a photoreceptor fate by day 2.27,46 RA addition at day 0 neither
decreased proliferation nor promoted an early onset of
photoreceptor differentiation, as evidenced by the lack of
increase in Crx expression. This suggests that an early exit
from the cell cycle is not the main cause of RA-induced
apoptosis.
A clue to the differential effect of RA on apoptosis with time
in vitro might reside in its ability to activate the p38 MAPK
signaling pathway. This pathway has been associated with
stress responses and linked to regulation of apoptosis induced
by several insults in different systems.32–37 The p38 family
includes four known members (p38a, p38b, p38c, and p38d),
all of which share significant identity with each other.
Members of the p38 family exhibit serine-kinase activities that,
in turn, activate or regulate other serine kinases. In the retina,
p38 activation leads to oxidative stress-induced apoptosis of a
retinal pigment epithelium cell line and to light-induced
apoptosis of the 661W cone-like cell line.53–55 RA effects in
vertebrates are mediated by its binding and activating two
families of nuclear receptors, RAR and RXR. These nuclear
receptors are ligand-dependent transcriptional regulators,
which induce gene transcription after binding to RA response
elements present in the promoters of RA-inducible genes.56,57
RARs are present in the developing neural retina,58 and
activation of the p38 MAPK in response to RA is involved in
the turnover of some RAR subunits and in RA-induced
transactivation activity.32,59,60 Our results demonstrated that
RA activated the p38 MAPK pathway in retina photoreceptors
at early times in culture (Fig. 9). Activation of p38 was crucial
for the pro-apoptotic effect of RA, since inhibiting this
activation completely prevented RA-induced apoptosis in
photoreceptors. Moreover, when added at day 2, RA was
unable to increase P-p38 levels and, therefore, no longer
induced photoreceptor apoptosis. RA did not affect the levels
TABLE 5. Effects of RA on Cell Cycle Progression
Hours
In Vitro Treatment
Nestinþ/Total
Cell N, %
p27 þ/Total
Cell N, %
Pax6 þ/Total
Cell N, %
12 EtOH 32.5 6 6.2 48.8 6 4.9 13.6 6 2.2
RA 29.9 6 4.2 43.9 6 4.8 12.2 6 1.0
24 EtOH 15.2 6 3.5 25.4 6 5.6 –
RA 12.3 6 3.1 27.7 6 3.9 –
48 EtOH 3.3 6 1.2 21.6 6 2.5 6.8 6 2.5
RA 4.2 6 1.1 25.3 6 4.3 6.0 6 4.3
Retinal cell cultures were prepared from PN0 and treated with
vehicle (EtOH) or with RA at day 0, as indicated in Table 4. The
percentage of cells expressing p27kip1 and the neuroectoderm marker
nestin was determined after 12, 24, and 48 hours in vitro. The
percentage of cells remaining in the cell cycle was established after 12
or 48 hours by determining the percentage of cells solely evidencing
Pax6 expression at culture times; cells double labeled with Pax6 and
HPC1, that is, amacrine neurons, were excluded.
TABLE 6. Effects of RA on Cell Fate Determination
Days
In Vitro Marker Treatment
Markerþ/
Total Cell N, %
1 Crx EtOH 63.5 6 2.0
RA 66.8 6 0.7
HPC1 EtOH 26.3 6 2.1
RA 26.4 6 1.7
2 Crx EtOH 69.1 6 3.4
RA 69.4 6 6.8
HPC1 EtOH 25.4 6 3.1
RA 27.9 6 3.8
Retinal cell cultures were prepared from PN0 retinas and treated
with vehicle (EtOH) or with RA, as indicated in Table 4. The
percentages of cells expressing Crx or HPC1 were determined by
immunocytochemistry after 1 or 2 days in vitro.
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of phosphorylated ERK, implying that its induction of
apoptosis did not involve modulation of the ERK/MAPK. These
results suggested that at early developmental stages RA triggers
apoptosis in photoreceptors through the activation of the p38
MAPK pathway; developmental changes lead to the loss of RA
capacity to activate this pathway and, consequently, to the loss
of its pro-apoptotic effect (Fig. 9).
The finding that RA did not induce the apoptosis of
amacrine cells supports the hypothesis that activation of the
p38 MAPK pathway is essential for its pro-apoptotic effect.
Activation of this pathway, as evidenced by an increase in P-
p38 levels, was observed chiefly in photoreceptors, suggesting
it either was absent or not responsive to RA in amacrine
neurons. This implies that different signals and signaling
cascades are involved in the decision between death and
survival in amacrine and photoreceptor neurons.
DHA, which rescues photoreceptors from apoptosis during
their development in vitro,4,61 also prevented the untimely
photoreceptor death induced by RA. DHA protection involves
the activation of the ERK/MAPK survival pathway in photore-
ceptors38 and our data suggested that this pathway was not
regulated by RA. DHA protection did not involve blocking RA
activation of the p38 pathway, since P-p38 levels were similar
in cultures treated with RA in the presence or absence of DHA.
Moreover, DHA protected photoreceptors from apoptosis in
spite of RA activation of the p38 pathway. RA has been shown
to induce cell death by phosphorylating and modulating the
activity of BimEL, a member of the Bcl-2 family
62; however,
phosphorylation of BimEL by ERK1/2 at additional sites
antagonizes apoptosis.63–65 Hence, through activation of the
ERK/MAPK pathway DHA might have a crucial role in blocking
RA-induced apoptosis in photoreceptors (Fig. 9).
In vivo, development of photoreceptors is a multistep
process; once they exit the cell cycle, photoreceptors start to
express specific proteins and develop a connecting cilium, at
the tip of which opsin-enriched membranes are assembled. In
vitro, the differentiation of photoreceptors seems to be
arrested in the absence of trophic factors, with photoreceptors
resembling their immature in vivo counterparts27; few of them
express opsin and peripherin and even fewer develop apical
processes. RA regulates different steps in photoreceptor
development. It increases differentiation in chick photorecep-
tors,13 accelerates the onset of opsin expression in cultured rat
retina explants and retina neurons,16,17 and is required for the
proper organization of nascent outer segment membranes in
Xenopus laevis tadpoles.66 Our results showed that RA rapidly
advanced photoreceptor differentiation in culture. RA promot-
ed an early onset of opsin expression, increased the levels of
FIGURE 9. Mechanisms of RA effects on retina photoreceptors. During early stages of retina development (left panel), when retina progenitors still
were progressing in the cell cycle, RA bound and activated its nuclear receptors (RAR and RXR) to activate the p38 MAPK signaling pathway.
Activation of this pathway was crucial for induction of apoptosis and also involved in promoting photoreceptor differentiation, together with other
signaling cascades, which are likely to be triggered by RAR/RXR activation. DHA, a photoreceptor trophic factor, prevented cell death probably by
activating the ERK/MAPK pathway,38 which blocked the apoptotic signal downstream of p38 activation. In post mitotic photoreceptors (right
panel) RA lost its capacity to activate the p38 pathway and no longer induced apoptosis; however, it still promoted differentiation, most likely by
acting through other, still undefined, signaling pathways.
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peripherin, and stimulated the formation of apical processes.
RA also promoted neurite outgrowth in photoreceptors. RA
has a crucial role in the induction of rod photoreceptor cell
fate, in embryonic retinas from rat and zebrafish,10,15,44 in
retinal progenitor cells derived from mouse and human stem
cells, and in Mu¨ller glia-derived retinal progenitors.67,68 During
retina neurogenesis in zebrafish, RA influences a rod versus
cone photoreceptor cell fate,69 and it induces retinal progen-
itors to acquire a photoreceptor cell fate in E15 and E18 rat
embryos.10 Since RA did not affect photoreceptor cell fate in
retinal progenitors, our data supported that the higher number
of cells exhibiting opsin and peripherin expression in RA-
supplemented cultures resulted from an early activation of
their development as photoreceptors.
In contrast with its effect on apoptosis, RA enhancement of
photoreceptor differentiation was independent of the pres-
ence of proliferating cells. Inhibiting the p38 MAPK pathway
partially blocked RA effect on differentiation. Since this
pathway is activated only at early stages of photoreceptor
development, these data suggested that the p38 signaling
pathway is a relevant, though not the only pathway involved in
stimulating photoreceptors differentiation. Thus, RA would
activate the selective transcription of genes involved in
photoreceptor differentiation through different pathways at
different stages of development (Fig. 9). Photoreceptor trophic
factors, such as FGFb and DHA, also activate the ERK/MAPK
signaling cascade38 to promote opsin expression. Interestingly,
the combined addition of RA and DHA to the cultures led to an
additive effect on the amount of opsin-expressing photorecep-
tors. These results imply that RA and DHA activate indepen-
dent pathways to advance photoreceptor differentiation.
Blocking apoptosis with a caspase inhibitor did not increase
the amount of differentiated photoreceptors, as might be
expected from increasing the pool of viable photoreceptors.
This suggested that RA stimulation of differentiation and its
triggering of apoptosis affect specific photoreceptor pools.
Alternatively, photoreceptors that were meant to die through
an apoptotic pathway might be arrested in their development
at a stage that makes them unable to initiate their differenti-
ation, even if caspase-mediated cell death is interrupted.
RA stimulation of neurite sprouting and outgrowth in
photoreceptors and amacrine cells also might involve activa-
tion of RAR, since retinoids have been shown to activate RARb2
to promote neurite outgrowth of cultured embryonic dorsal
root ganglia (DRG), and spinal cord and adult DRG.70–72
Inhibition of p38 MAPK did not prevent this stimulation,
suggesting that RA activated other intracellular pathways to
promote neurite elongation. Stimulation of neurite outgrowth
was the only observed effect of RA in amacrine neurons, and
lack of involvement of the p38 MAPK pathway in this effect is
consistent with the evidence that RA only activated p38 in
photoreceptors. Activation of insulin receptors has been
shown to promote neurite outgrowth in photoreceptors and
amacrine neurons,26,73 the PI3K signaling pathway.74 Estab-
lishing whether RA activates this pathway to promote neurite
outgrowth in these cells requires further research.
Development of photoreceptors depends on many factors,
with RA having a crucial role. While approximately 50% of
amacrine neurons disappear during retina development, only
5% of the initially generated photoreceptors die.31 This implies
that a precise synchronization in the supply of the molecular
signals essential for photoreceptor development is crucial; an
untimely provision of RA in the absence of survival molecules
might activate apoptosis. Our results underscore the relevance
of a fine balance between the molecules and mechanisms
regulating genesis and differentiation of photoreceptors, and
those promoting their survival to achieve the precise number
of photoreceptors for adequate visual function.
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